ABStRACt
iNtRODUCtiON
Fluorodeoxyglucose (FDG) positron-emission tomography/computed tomography (PET-CT) plays an important role in management of patients with malignancies in the 21st century. To achieve accurate PET-CT interpretation, it is necessary to be aware of false-positive findings such as physiological FDG uptake, normal variants, and other artificial conditions. This report is of incidental focal 18 F-FDG accumulation without abnormal CT findings in the lung parenchyma of a patient with a history of Burkitt lymphoma and bilateral varicose veins. The markedly 18 F-FDGavid accumulation had disappeared by the time of the follow-up PET-CT scan performed 7 weeks later, while a new 18 F-FDG-avid focus had appeared in the contralateral lung field. In both PET-CT studies, successful intravenous injection was performed at the first attempt via the lower limbs with the varicose veins, with no evidence of paravenous injection. To the authors' knowledge, this is the first report of such an artefact in a patient with 18 F-FDG passing through the varicose veins after injection into the foot. This report illustrates an example of potential false-positive PET-CT interpretation of an artefact that may be wrongly interpreted as a pathological entity.
CASE REPORt
A woman presented with a history of a right breast mass in 1989, which was clinically stage IA. The biopsy revealed Burkitt lymphoma, and she was treated with six courses of chemotherapy, followed by external radiation therapy to the right breast. Complete disease remission was achieved for more than 20 years. The same patient, who was then 58 years old, presented with bilateral lower limb varicose veins and was referred to the Nuclear Medicine Unit, Queen Elizabeth Hospital, Hong Kong on 24 May 2011 for PET-CT to exclude a suspected relapse. In the same month, she had attended the Hong Kong Eye Hospital for prolonged unresolved right upper eyelid erythema. The patient was afebrile and all laboratory investigations were unremarkable, including serum lactate dehydrogenase. In the follow-up PET/CT on 13 July 2011, the 
DiSCUSSiON
Clinical utility of 18 F-FDG PET-CT has greatly advanced in the 21st century. PET-CT is one of the most effective and non-invasive imaging modalities, particularly in the field of oncology. The major benefit of integrated PET-CT is its unique ability to offer simultaneous anatomical and functional information. However, there are potential pitfalls for PET-CT misinterpretation, including 18 F-FDG uptake in benign lesions or normal variants related to a patient's clinical history.
1,2 Misalignment between PET and CT resulting from time lag between scans or patient repositioning should also be noted. 3 This patient had artefacts of incidental 18 F-FDG accumulation in the lung parenchyma with no corresponding abnormality on CT. The absence of a structural pulmonary lesion seen by CT should alert the physician that the corresponding markedly 18 F-FDG-avid focus is likely to be an artefact rather than an additional pathological entity. One of the most likely possibilities to account for this interesting finding could be microembolus formation during the injection process. The markedly 18 F-FDGavid microembolus could reach and deposit in the small vascular structures of the lung parenchyma. 4, 5 Indeed, microembolus formation remains one of the known complications of venous catheterization.
6,7 A thrombus F-FDG uptake. 9 This patient had a history of bilateral lower limb varicose veins, which is a known risk factor for venous thromboembolism. 10, 11 Although the underlying cause of the markedly 18 F-FDG-avid microembolus formations in this patient could not be exactly ascertained, in the absence of paravenous injection it is likely that microembolus formation originated from previously formed vascular thrombi, probably caused by phlebitis or reduced blood flow rate through the varicose veins. The microembolus subsequently became detached from the vascular walls and reached the pulmonary circulation. 12 It is possible that 18 F-FDGavid microembolus may arise from the tracer travelling through the varicose veins, as illustrated by this patient. Although this theory is unconfirmed, it may be one of the causes of this artefact. Further studies are required to delineate the underlying causes of this rare and interesting phenomenon. To prevent erroneous image interpretation, 18 F-FDG injection that may pass through varicose veins should be avoided. 
